

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.43732291 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.40352105 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 8.40288600 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.78656729 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.78656729 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.43874078 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.43874078 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.88669028 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.43586119 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.07153598 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.07153598 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.07153598 |
| 13 | drug metabolic process (GO:0017144) | 6.00146435 |
| 14 | urea cycle (GO:0000050) | 5.99227968 |
| 15 | urea metabolic process (GO:0019627) | 5.99227968 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.96286926 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.84729688 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.73494637 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.73084511 |
| 20 | oxidative demethylation (GO:0070989) | 5.65919823 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.63053213 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 5.62274568 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.58881679 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 5.50998134 |
| 25 | regulation of plasminogen activation (GO:0010755) | 5.47759084 |
| 26 | cysteine metabolic process (GO:0006534) | 5.46518409 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 5.44780893 |
| 28 | ethanol metabolic process (GO:0006067) | 5.41109463 |
| 29 | regulation of fibrinolysis (GO:0051917) | 5.34701978 |
| 30 | protein carboxylation (GO:0018214) | 5.29636035 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.29636035 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 5.25277510 |
| 33 | regulation of protein activation cascade (GO:2000257) | 5.08194888 |
| 34 | complement activation, alternative pathway (GO:0006957) | 5.06910955 |
| 35 | bile acid metabolic process (GO:0008206) | 5.04327781 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 5.01254033 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 5.00656615 |
| 38 | tyrosine metabolic process (GO:0006570) | 5.00583815 |
| 39 | homocysteine metabolic process (GO:0050667) | 5.00280744 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.91560363 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.87048071 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.85235616 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.84461342 |
| 44 | macromolecular complex remodeling (GO:0034367) | 4.84461342 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.84461342 |
| 46 | phenylpropanoid metabolic process (GO:0009698) | 4.84104114 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.81809473 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.79280868 |
| 49 | negative regulation of hemostasis (GO:1900047) | 4.79280868 |
| 50 | regulation of humoral immune response (GO:0002920) | 4.77167457 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.74179756 |
| 52 | regulation of complement activation (GO:0030449) | 4.69968545 |
| 53 | phospholipid efflux (GO:0033700) | 4.65305526 |
| 54 | lysine catabolic process (GO:0006554) | 4.61607235 |
| 55 | lysine metabolic process (GO:0006553) | 4.61607235 |
| 56 | opsonization (GO:0008228) | 4.60856201 |
| 57 | triglyceride homeostasis (GO:0070328) | 4.59765273 |
| 58 | acylglycerol homeostasis (GO:0055090) | 4.59765273 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.59007342 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.59007342 |
| 61 | negative regulation of protein activation cascade (GO:2000258) | 4.58012326 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.52625618 |
| 63 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.46475305 |
| 64 | glycine metabolic process (GO:0006544) | 4.42566714 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 4.41452945 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 4.40703150 |
| 67 | intestinal cholesterol absorption (GO:0030299) | 4.39907990 |
| 68 | negative regulation of coagulation (GO:0050819) | 4.36009168 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 4.35976870 |
| 70 | coenzyme catabolic process (GO:0009109) | 4.31699906 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 4.31595934 |
| 72 | bile acid and bile salt transport (GO:0015721) | 4.30878749 |
| 73 | glutamate metabolic process (GO:0006536) | 4.30708236 |
| 74 | negative regulation of wound healing (GO:0061045) | 4.30288504 |
| 75 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.29594332 |
| 76 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.29594332 |
| 77 | cytolysis (GO:0019835) | 4.29203106 |
| 78 | cholesterol efflux (GO:0033344) | 4.25529505 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 4.21996758 |
| 80 | positive regulation of blood coagulation (GO:0030194) | 4.21984087 |
| 81 | positive regulation of hemostasis (GO:1900048) | 4.21984087 |
| 82 | arginine metabolic process (GO:0006525) | 4.21880524 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 4.20839956 |
| 84 | amine catabolic process (GO:0009310) | 4.20839956 |
| 85 | cellular glucuronidation (GO:0052695) | 4.15737734 |
| 86 | cellular modified amino acid catabolic process (GO:0042219) | 4.12050066 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 4.08727034 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 4.08054480 |
| 89 | benzene-containing compound metabolic process (GO:0042537) | 4.07949853 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.06278374 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 4.04663547 |
| 92 | aldehyde catabolic process (GO:0046185) | 4.03064032 |
| 93 | alkaloid metabolic process (GO:0009820) | 4.02242283 |
| 94 | fibrinolysis (GO:0042730) | 3.96075135 |
| 95 | ethanol oxidation (GO:0006069) | 3.94170857 |
| 96 | drug catabolic process (GO:0042737) | 3.92365118 |
| 97 | ketone body metabolic process (GO:1902224) | 3.91768644 |
| 98 | positive regulation of coagulation (GO:0050820) | 3.88330877 |
| 99 | negative regulation of lipase activity (GO:0060192) | 3.83932792 |
| 100 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.81247003 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.81247003 |
| 102 | carboxylic acid catabolic process (GO:0046395) | 3.80815822 |
| 103 | organic acid catabolic process (GO:0016054) | 3.80815822 |
| 104 | response to mercury ion (GO:0046689) | 3.80703701 |
| 105 | blood coagulation, intrinsic pathway (GO:0007597) | 3.79633910 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 3.79161084 |
| 107 | regulation of apoptotic cell clearance (GO:2000425) | 3.77269951 |
| 108 | cofactor catabolic process (GO:0051187) | 3.75548757 |
| 109 | phospholipid homeostasis (GO:0055091) | 3.73969488 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.73360361 |
| 111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73289875 |
| 112 | regulation of bile acid biosynthetic process (GO:0070857) | 3.72696454 |
| 113 | glucuronate metabolic process (GO:0019585) | 3.68385137 |
| 114 | uronic acid metabolic process (GO:0006063) | 3.68385137 |
| 115 | sterol homeostasis (GO:0055092) | 3.67119930 |
| 116 | plasma lipoprotein particle organization (GO:0071827) | 3.66698160 |
| 117 | short-chain fatty acid metabolic process (GO:0046459) | 3.64541654 |
| 118 | regulation of cholesterol homeostasis (GO:2000188) | 3.62966079 |
| 119 | protein-lipid complex assembly (GO:0065005) | 3.62778907 |
| 120 | negative regulation of complement activation (GO:0045916) | 3.61512289 |
| 121 | acetyl-CoA metabolic process (GO:0006084) | 3.61124042 |
| 122 | protein activation cascade (GO:0072376) | 3.58823299 |
| 123 | acute inflammatory response (GO:0002526) | 3.58614704 |
| 124 | hormone catabolic process (GO:0042447) | 3.55608802 |
| 125 | complement activation, classical pathway (GO:0006958) | 3.55128673 |
| 126 | complement activation (GO:0006956) | 3.54870404 |
| 127 | acute-phase response (GO:0006953) | 3.54186098 |
| 128 | flavonoid metabolic process (GO:0009812) | 3.54117130 |
| 129 | NAD biosynthetic process (GO:0009435) | 3.52029698 |
| 130 | * S-adenosylmethionine metabolic process (GO:0046500) | 3.50334195 |
| 131 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.48962873 |
| 132 | heme transport (GO:0015886) | 3.46962750 |
| 133 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.43400213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.46764152 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21535049 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.87753333 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.53926376 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28536962 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.12975319 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.89817133 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99771007 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.93088054 |
| 10 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06172774 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00449727 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00047194 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0039152 |
| 14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60536531 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56537278 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52792334 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45396666 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40781374 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31513083 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.22829610 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18289331 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17783604 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12604186 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.09717877 |
| 25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07637769 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00496892 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97614860 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94828172 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92860406 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91299313 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84832155 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84482886 |
| 33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84168426 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83861722 |
| 35 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83796219 |
| 36 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80896684 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80881655 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.80363256 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79011581 |
| 40 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77060068 |
| 41 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75783716 |
| 42 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.74818237 |
| 43 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74155177 |
| 44 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73690490 |
| 45 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72859228 |
| 46 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.72777226 |
| 47 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.71879666 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70507227 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70329506 |
| 50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69575279 |
| 51 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.69391626 |
| 52 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68113342 |
| 53 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.68067541 |
| 54 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.65779744 |
| 55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.65732982 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65038704 |
| 57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64812126 |
| 58 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.64531160 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63168196 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62656719 |
| 61 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62405231 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62195169 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62195169 |
| 64 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61822716 |
| 65 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61355076 |
| 66 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60878863 |
| 67 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60701143 |
| 68 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.59439009 |
| 69 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.58355677 |
| 70 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.57185563 |
| 71 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57158351 |
| 72 | NFYA_21822215_ChIP-Seq_K562_Human | 0.56941315 |
| 73 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.55966766 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.55701797 |
| 75 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55495326 |
| 76 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.55153455 |
| 77 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.54396041 |
| 78 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.54277503 |
| 79 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.54187651 |
| 80 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.53507076 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.53122976 |
| 82 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.52717166 |
| 83 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52600420 |
| 84 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52510108 |
| 85 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52463499 |
| 86 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.52195370 |
| 87 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52102404 |
| 88 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.52090438 |
| 89 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52034732 |
| 90 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.51686955 |
| 91 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51162157 |
| 92 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49537666 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49038066 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.49035400 |
| 95 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.48576044 |
| 96 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.48462281 |
| 97 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48433522 |
| 98 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.48189905 |
| 99 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.47864007 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.47791918 |
| 101 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.47787572 |
| 102 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.47784551 |
| 103 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.47319983 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46379792 |
| 105 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45955062 |
| 106 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.45635540 |
| 107 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45417578 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44361492 |
| 109 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42888808 |
| 110 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.42540695 |
| 111 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42396505 |
| 112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.42249850 |
| 113 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41969616 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41574709 |
| 115 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.41415849 |
| 116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41363871 |
| 117 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40023314 |
| 118 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39753875 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.38884646 |
| 120 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38820170 |
| 121 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38589077 |
| 122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38124520 |
| 123 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.38072779 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38040554 |
| 125 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36219557 |
| 126 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.35914077 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.34847079 |
| 128 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.33661261 |
| 129 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33515065 |
| 130 | NCOR_22424771_ChIP-Seq_293T_Human | 0.33322194 |
| 131 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33150557 |
| 132 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.32968419 |
| 133 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.32931764 |
| 134 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.32830719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.20641316 |
| 2 | MP0005360_urolithiasis | 7.47424085 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.43181394 |
| 4 | MP0005365_abnormal_bile_salt | 6.24433390 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.17694645 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.19134940 |
| 7 | MP0003252_abnormal_bile_duct | 3.90021641 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58889146 |
| 9 | MP0009840_abnormal_foam_cell | 3.39544718 |
| 10 | MP0005083_abnormal_biliary_tract | 3.15521345 |
| 11 | MP0003195_calcinosis | 2.91459812 |
| 12 | * MP0005332_abnormal_amino_acid | 2.76200901 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.61784830 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.40293924 |
| 15 | * MP0000609_abnormal_liver_physiology | 2.14079630 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.13925143 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.11686942 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.05907574 |
| 19 | MP0003868_abnormal_feces_composition | 1.97339144 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.81829430 |
| 21 | MP0001764_abnormal_homeostasis | 1.71057821 |
| 22 | MP0005451_abnormal_body_composition | 1.67320653 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57637930 |
| 24 | MP0009697_abnormal_copulation | 1.55945480 |
| 25 | MP0003011_delayed_dark_adaptation | 1.37192290 |
| 26 | MP0003186_abnormal_redox_activity | 1.29388396 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.26049375 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.25194052 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.18487147 |
| 30 | MP0002132_abnormal_respiratory_system | 1.17456340 |
| 31 | * MP0000598_abnormal_liver_morphology | 1.16316537 |
| 32 | MP0000604_amyloidosis | 1.11218582 |
| 33 | MP0005647_abnormal_sex_gland | 1.06003198 |
| 34 | MP0009764_decreased_sensitivity_to | 1.04292959 |
| 35 | MP0009763_increased_sensitivity_to | 1.02577889 |
| 36 | MP0002254_reproductive_system_inflammat | 1.00165460 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 0.91361215 |
| 38 | MP0010368_abnormal_lymphatic_system | 0.91020413 |
| 39 | MP0001915_intracranial_hemorrhage | 0.90167318 |
| 40 | MP0005670_abnormal_white_adipose | 0.88466298 |
| 41 | MP0008469_abnormal_protein_level | 0.87705101 |
| 42 | * MP0009642_abnormal_blood_homeostasis | 0.87009426 |
| 43 | MP0005408_hypopigmentation | 0.86386027 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 0.82646237 |
| 45 | MP0002078_abnormal_glucose_homeostasis | 0.81254474 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.80832273 |
| 47 | MP0009765_abnormal_xenobiotic_induced | 0.79309266 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 0.78044532 |
| 49 | MP0002282_abnormal_trachea_morphology | 0.76612879 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 0.75802111 |
| 51 | MP0003879_abnormal_hair_cell | 0.74905014 |
| 52 | MP0002876_abnormal_thyroid_physiology | 0.74324867 |
| 53 | MP0002971_abnormal_brown_adipose | 0.73716505 |
| 54 | MP0004130_abnormal_muscle_cell | 0.70541285 |
| 55 | MP0001661_extended_life_span | 0.70243241 |
| 56 | MP0005334_abnormal_fat_pad | 0.69404266 |
| 57 | MP0003690_abnormal_glial_cell | 0.68982073 |
| 58 | MP0005535_abnormal_body_temperature | 0.66724316 |
| 59 | MP0003329_amyloid_beta_deposits | 0.65499331 |
| 60 | MP0002249_abnormal_larynx_morphology | 0.65461000 |
| 61 | MP0009053_abnormal_anal_canal | 0.65232073 |
| 62 | MP0005266_abnormal_metabolism | 0.65120167 |
| 63 | MP0001756_abnormal_urination | 0.62995326 |
| 64 | MP0000639_abnormal_adrenal_gland | 0.62890764 |
| 65 | MP0005187_abnormal_penis_morphology | 0.62273833 |
| 66 | MP0000566_synostosis | 0.61509853 |
| 67 | MP0005448_abnormal_energy_balance | 0.58299022 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 0.56304821 |
| 69 | MP0005023_abnormal_wound_healing | 0.55966551 |
| 70 | MP0005464_abnormal_platelet_physiology | 0.55117364 |
| 71 | MP0005395_other_phenotype | 0.49592149 |
| 72 | MP0003638_abnormal_response/metabolism_ | 0.48170003 |
| 73 | MP0002822_catalepsy | 0.47253784 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 0.46982891 |
| 75 | MP0008874_decreased_physiological_sensi | 0.46525171 |
| 76 | MP0008873_increased_physiological_sensi | 0.45520813 |
| 77 | MP0002136_abnormal_kidney_physiology | 0.45098813 |
| 78 | MP0002928_abnormal_bile_duct | 0.44875356 |
| 79 | MP0003718_maternal_effect | 0.44657030 |
| 80 | MP0005248_abnormal_Harderian_gland | 0.43347726 |
| 81 | MP0009785_altered_susceptibility_to | 0.42342391 |
| 82 | MP0003436_decreased_susceptibility_to | 0.42226080 |
| 83 | MP0003953_abnormal_hormone_level | 0.42208575 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.41461862 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.39915858 |
| 86 | MP0003724_increased_susceptibility_to | 0.39769205 |
| 87 | MP0003075_altered_response_to | 0.39721851 |
| 88 | MP0008872_abnormal_physiological_respon | 0.37373697 |
| 89 | MP0009672_abnormal_birth_weight | 0.36990802 |
| 90 | MP0002089_abnormal_postnatal_growth/wei | 0.36226511 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.34749105 |
| 92 | MP0001243_abnormal_dermal_layer | 0.33613711 |
| 93 | MP0004883_abnormal_blood_vessel | 0.33239814 |
| 94 | MP0000249_abnormal_blood_vessel | 0.33135774 |
| 95 | MP0009115_abnormal_fat_cell | 0.33085623 |
| 96 | MP0002168_other_aberrant_phenotype | 0.33050167 |
| 97 | MP0005166_decreased_susceptibility_to | 0.32975701 |
| 98 | MP0000467_abnormal_esophagus_morphology | 0.32038448 |
| 99 | MP0002970_abnormal_white_adipose | 0.30871693 |
| 100 | MP0000579_abnormal_nail_morphology | 0.29940786 |
| 101 | MP0001853_heart_inflammation | 0.29164350 |
| 102 | MP0006082_CNS_inflammation | 0.28787795 |
| 103 | MP0002796_impaired_skin_barrier | 0.26903317 |
| 104 | MP0004381_abnormal_hair_follicle | 0.26902509 |
| 105 | MP0001881_abnormal_mammary_gland | 0.26438029 |
| 106 | * MP0001845_abnormal_inflammatory_respons | 0.25817556 |
| 107 | MP0003878_abnormal_ear_physiology | 0.25314924 |
| 108 | MP0005377_hearing/vestibular/ear_phenot | 0.25314924 |
| 109 | MP0002090_abnormal_vision | 0.25277270 |
| 110 | MP0005164_abnormal_response_to | 0.25092404 |
| 111 | MP0009384_cardiac_valve_regurgitation | 0.24511702 |
| 112 | MP0001851_eye_inflammation | 0.24135657 |
| 113 | MP0005058_abnormal_lysosome_morphology | 0.23385151 |
| 114 | MP0001944_abnormal_pancreas_morphology | 0.22844712 |
| 115 | MP0003632_abnormal_nervous_system | 0.21430652 |
| 116 | MP0002909_abnormal_adrenal_gland | 0.19809206 |
| 117 | MP0000920_abnormal_myelination | 0.19010690 |
| 118 | MP0003172_abnormal_lysosome_physiology | 0.18611979 |
| 119 | MP0002128_abnormal_blood_circulation | 0.17851947 |
| 120 | MP0005197_abnormal_uvea_morphology | 0.17496323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.67940721 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.36547702 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.10844843 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.02650183 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.50396517 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.47842473 |
| 7 | Xanthomatosis (HP:0000991) | 6.32721746 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.73201038 |
| 9 | Complement deficiency (HP:0004431) | 4.97789676 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.88634883 |
| 11 | Hyperammonemia (HP:0001987) | 4.76846600 |
| 12 | Joint hemorrhage (HP:0005261) | 4.76581324 |
| 13 | Epidermoid cyst (HP:0200040) | 4.57401641 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.48678883 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.47643119 |
| 16 | Hyperglycinemia (HP:0002154) | 4.38650110 |
| 17 | Ketosis (HP:0001946) | 4.34717091 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.32902566 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.31635604 |
| 20 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.14510055 |
| 21 | * Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.07833816 |
| 22 | Fat malabsorption (HP:0002630) | 4.01551157 |
| 23 | * Abnormality of methionine metabolism (HP:0010901) | 3.95235665 |
| 24 | Hyperglycinuria (HP:0003108) | 3.93667194 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.93060411 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.90833229 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90833229 |
| 28 | * Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.88887392 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71959284 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.69336154 |
| 31 | Abnormality of complement system (HP:0005339) | 3.62358991 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.61293311 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.43490144 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.39770251 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.35790719 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.18345520 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.17001946 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.10508948 |
| 39 | Spontaneous abortion (HP:0005268) | 3.07659082 |
| 40 | Ketoacidosis (HP:0001993) | 3.06205091 |
| 41 | Steatorrhea (HP:0002570) | 2.99084428 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.97450867 |
| 43 | Myocardial infarction (HP:0001658) | 2.88360425 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.85170002 |
| 45 | Skin nodule (HP:0200036) | 2.84587111 |
| 46 | Metabolic acidosis (HP:0001942) | 2.82969435 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.70263253 |
| 48 | Osteomalacia (HP:0002749) | 2.70239583 |
| 49 | Purpura (HP:0000979) | 2.68743162 |
| 50 | Lethargy (HP:0001254) | 2.68473543 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62464047 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.62464047 |
| 53 | Vascular calcification (HP:0004934) | 2.58890415 |
| 54 | Cerebral edema (HP:0002181) | 2.56519241 |
| 55 | Spastic diplegia (HP:0001264) | 2.54692076 |
| 56 | Acanthocytosis (HP:0001927) | 2.54021865 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.53031030 |
| 58 | Hypoglycemic seizures (HP:0002173) | 2.51496334 |
| 59 | Glomerulonephritis (HP:0000099) | 2.50021156 |
| 60 | Irritability (HP:0000737) | 2.45560795 |
| 61 | Gout (HP:0001997) | 2.44938755 |
| 62 | Mitral stenosis (HP:0001718) | 2.42451892 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.40487246 |
| 64 | Neonatal onset (HP:0003623) | 2.38976558 |
| 65 | Amyloidosis (HP:0011034) | 2.36777286 |
| 66 | Cholelithiasis (HP:0001081) | 2.33904490 |
| 67 | Pulmonary embolism (HP:0002204) | 2.32974649 |
| 68 | Fair hair (HP:0002286) | 2.31226917 |
| 69 | Malnutrition (HP:0004395) | 2.30277487 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.29494992 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.27920929 |
| 72 | Cholecystitis (HP:0001082) | 2.27920929 |
| 73 | Gingival bleeding (HP:0000225) | 2.24036479 |
| 74 | Neonatal hypoglycemia (HP:0001998) | 2.22771390 |
| 75 | Esophageal varix (HP:0002040) | 2.19036715 |
| 76 | Menorrhagia (HP:0000132) | 2.16762492 |
| 77 | Pancreatitis (HP:0001733) | 2.16489384 |
| 78 | Brushfield spots (HP:0001088) | 2.16448322 |
| 79 | Late onset (HP:0003584) | 2.15829306 |
| 80 | Enlarged kidneys (HP:0000105) | 2.12362080 |
| 81 | Vomiting (HP:0002013) | 2.11670157 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.10336859 |
| 83 | Thrombophlebitis (HP:0004418) | 2.09489678 |
| 84 | Generalized aminoaciduria (HP:0002909) | 2.08126347 |
| 85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.06653073 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05832307 |
| 87 | Opisthotonus (HP:0002179) | 2.02204989 |
| 88 | Joint swelling (HP:0001386) | 2.00042219 |
| 89 | Hyperphosphaturia (HP:0003109) | 1.99995726 |
| 90 | Poikilocytosis (HP:0004447) | 1.99992581 |
| 91 | Alkalosis (HP:0001948) | 1.99619700 |
| 92 | Abnormality of vitamin metabolism (HP:0100508) | 1.97142005 |
| 93 | Arthropathy (HP:0003040) | 1.96590928 |
| 94 | Reduced antithrombin III activity (HP:0001976) | 1.95837302 |
| 95 | Abnormality of the gallbladder (HP:0005264) | 1.93941701 |
| 96 | Hemorrhage of the eye (HP:0011885) | 1.93522741 |
| 97 | Abnormality of the Achilles tendon (HP:0005109) | 1.93094476 |
| 98 | Rickets (HP:0002748) | 1.90077971 |
| 99 | Elevated alkaline phosphatase (HP:0003155) | 1.90013124 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 1.89199732 |
| 101 | Abnormal cartilage morphology (HP:0002763) | 1.88653670 |
| 102 | Renal cortical cysts (HP:0000803) | 1.87858026 |
| 103 | Bifid scrotum (HP:0000048) | 1.87191235 |
| 104 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86481454 |
| 105 | Increased serum ferritin (HP:0003281) | 1.85902510 |
| 106 | Hydroxyprolinuria (HP:0003080) | 1.85123814 |
| 107 | Abnormality of proline metabolism (HP:0010907) | 1.85123814 |
| 108 | Abnormality of urine glucose concentration (HP:0011016) | 1.83648665 |
| 109 | Glycosuria (HP:0003076) | 1.83648665 |
| 110 | Elevated hepatic transaminases (HP:0002910) | 1.82551641 |
| 111 | Hypophosphatemic rickets (HP:0004912) | 1.82133230 |
| 112 | Status epilepticus (HP:0002133) | 1.80778050 |
| 113 | Gangrene (HP:0100758) | 1.79015690 |
| 114 | Epistaxis (HP:0000421) | 1.77358148 |
| 115 | Hyperglycemia (HP:0003074) | 1.77258498 |
| 116 | Increased mean platelet volume (HP:0011877) | 1.75776929 |
| 117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75349301 |
| 118 | Proximal tubulopathy (HP:0000114) | 1.75348815 |
| 119 | Nephritis (HP:0000123) | 1.75060828 |
| 120 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73911622 |
| 121 | Abnormal urine phosphate concentration (HP:0012599) | 1.64179888 |
| 122 | Abnormal delivery (HP:0001787) | 1.63811290 |
| 123 | Generalized hypopigmentation of hair (HP:0011358) | 1.57543628 |
| 124 | Abnormal platelet volume (HP:0011876) | 1.57236359 |
| 125 | Abnormal platelet function (HP:0011869) | 1.54741278 |
| 126 | Impaired platelet aggregation (HP:0003540) | 1.54741278 |
| 127 | Increased serum pyruvate (HP:0003542) | 1.52384965 |
| 128 | Cerebral palsy (HP:0100021) | 1.52208932 |
| 129 | Reticulocytosis (HP:0001923) | 1.50521750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.34871217 |
| 2 | FGFR4 | 4.49081026 |
| 3 | SIK1 | 4.48219841 |
| 4 | ERN1 | 4.32310646 |
| 5 | INSRR | 3.18701618 |
| 6 | TAOK3 | 3.02335561 |
| 7 | ERBB4 | 2.62967151 |
| 8 | PKN2 | 2.44336211 |
| 9 | MAP2K4 | 2.38390784 |
| 10 | PIK3CA | 2.21088449 |
| 11 | FLT3 | 2.06937958 |
| 12 | MST1R | 2.02046553 |
| 13 | PIK3CG | 1.96635598 |
| 14 | TRIB3 | 1.87367155 |
| 15 | MAPK11 | 1.78565535 |
| 16 | TYK2 | 1.64576294 |
| 17 | NTRK3 | 1.64187481 |
| 18 | LATS1 | 1.64030368 |
| 19 | PRPF4B | 1.61648001 |
| 20 | FRK | 1.53984814 |
| 21 | DAPK2 | 1.53321672 |
| 22 | PTK6 | 1.50741173 |
| 23 | ABL2 | 1.48346841 |
| 24 | FGFR2 | 1.35402940 |
| 25 | NEK9 | 1.33716824 |
| 26 | KDR | 1.29627728 |
| 27 | NLK | 1.24508441 |
| 28 | JAK2 | 1.20593511 |
| 29 | PINK1 | 1.17405884 |
| 30 | MAP3K7 | 1.13733278 |
| 31 | PRKAA2 | 1.11559780 |
| 32 | MAP2K3 | 1.07169551 |
| 33 | GRK6 | 1.04271990 |
| 34 | MAP3K10 | 1.04067148 |
| 35 | TBK1 | 1.03674686 |
| 36 | JAK1 | 1.01516177 |
| 37 | MAPK4 | 0.97207326 |
| 38 | CDK12 | 0.96292324 |
| 39 | ERBB2 | 0.95597012 |
| 40 | FER | 0.93257803 |
| 41 | PRKCZ | 0.91704952 |
| 42 | EPHB1 | 0.91500774 |
| 43 | MAP3K14 | 0.90730963 |
| 44 | MAPKAPK3 | 0.89698019 |
| 45 | MAP3K3 | 0.88950231 |
| 46 | MAPK15 | 0.86195119 |
| 47 | EPHA3 | 0.85478926 |
| 48 | PDGFRA | 0.85400420 |
| 49 | MET | 0.84755200 |
| 50 | PRKG1 | 0.84525905 |
| 51 | CDK6 | 0.82197349 |
| 52 | MAPK12 | 0.81218986 |
| 53 | STK38L | 0.76982944 |
| 54 | PDK2 | 0.76941179 |
| 55 | PRKACG | 0.76600708 |
| 56 | MAP3K11 | 0.76599231 |
| 57 | TIE1 | 0.74307255 |
| 58 | DYRK1B | 0.74172603 |
| 59 | CSK | 0.71093491 |
| 60 | PRKACA | 0.70815857 |
| 61 | MAP2K6 | 0.69938344 |
| 62 | GSK3A | 0.68575226 |
| 63 | CAMK2G | 0.67095363 |
| 64 | CSNK1E | 0.66785418 |
| 65 | TNK2 | 0.66101138 |
| 66 | EEF2K | 0.66000142 |
| 67 | SGK3 | 0.65058805 |
| 68 | PRKAA1 | 0.65045088 |
| 69 | MUSK | 0.64944196 |
| 70 | CAMK1D | 0.64920295 |
| 71 | AKT3 | 0.61421687 |
| 72 | KSR2 | 0.61188452 |
| 73 | RIPK1 | 0.61168235 |
| 74 | IRAK3 | 0.60365139 |
| 75 | MAPK7 | 0.59741560 |
| 76 | FGFR3 | 0.59707030 |
| 77 | WNK4 | 0.59609896 |
| 78 | SGK1 | 0.59107053 |
| 79 | PTK2 | 0.58854525 |
| 80 | CSNK1D | 0.58690497 |
| 81 | FGFR1 | 0.58122174 |
| 82 | TGFBR2 | 0.57091256 |
| 83 | PDPK1 | 0.54426606 |
| 84 | CSF1R | 0.54220547 |
| 85 | IKBKE | 0.52417407 |
| 86 | MYLK | 0.52381794 |
| 87 | RPS6KA3 | 0.51917755 |
| 88 | PRKCQ | 0.51318747 |
| 89 | CSNK1G1 | 0.50263326 |
| 90 | PRKCB | 0.48317732 |
| 91 | EIF2AK1 | 0.48038223 |
| 92 | ZAP70 | 0.47975243 |
| 93 | RET | 0.47688864 |
| 94 | SGK2 | 0.47143792 |
| 95 | EPHA4 | 0.47094108 |
| 96 | CAMKK2 | 0.46827188 |
| 97 | PRKACB | 0.46583436 |
| 98 | MAP2K1 | 0.45354198 |
| 99 | SRC | 0.45347050 |
| 100 | MAP3K5 | 0.45084248 |
| 101 | STK38 | 0.44757003 |
| 102 | IGF1R | 0.44576384 |
| 103 | EPHA2 | 0.43783398 |
| 104 | TAOK2 | 0.43173051 |
| 105 | GRK1 | 0.41296461 |
| 106 | CDK4 | 0.40906508 |
| 107 | SMG1 | 0.40039954 |
| 108 | MAP3K13 | 0.40007160 |
| 109 | PRKCG | 0.39889833 |
| 110 | CSNK2A1 | 0.38116974 |
| 111 | CSNK2A2 | 0.37960463 |
| 112 | SCYL2 | 0.37233440 |
| 113 | MAP3K6 | 0.37091024 |
| 114 | MTOR | 0.36401498 |
| 115 | ICK | 0.36283685 |
| 116 | RPS6KB1 | 0.36273027 |
| 117 | MAP3K1 | 0.35045930 |
| 118 | PDK1 | 0.34677498 |
| 119 | STK16 | 0.33899351 |
| 120 | SGK223 | 0.33586992 |
| 121 | SGK494 | 0.33586992 |
| 122 | CAMK4 | 0.31115426 |
| 123 | CSNK1G2 | 0.31087762 |
| 124 | EGFR | 0.30796532 |
| 125 | IRAK1 | 0.30346029 |
| 126 | PBK | 0.29922235 |
| 127 | MAP2K2 | 0.29533998 |
| 128 | IRAK2 | 0.28092354 |
| 129 | CSNK1G3 | 0.27919106 |
| 130 | PKN1 | 0.27290873 |
| 131 | PRKCA | 0.25283308 |
| 132 | MAP3K2 | 0.24301446 |
| 133 | LATS2 | 0.22551065 |
| 134 | PAK3 | 0.21539338 |
| 135 | PDK3 | 0.20405195 |
| 136 | PDK4 | 0.20405195 |
| 137 | ABL1 | 0.19671009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.42287406 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.74515459 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.55969483 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.35079381 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.24587881 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71628260 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.66952549 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66278031 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.62904954 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60241799 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49933784 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39496710 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24321573 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13730815 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09604942 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06022935 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93059906 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92848849 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90957416 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.87992445 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86329924 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86115819 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.84953333 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79872557 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75694662 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73676014 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71961381 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66105309 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65311181 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63826847 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.62692077 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62084217 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60235781 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55806070 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55201547 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.45033405 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44691874 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35548869 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35283163 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30976823 |
| 41 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29984329 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24625996 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22375592 |
| 44 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19172391 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17408716 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.16759066 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13569828 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13265339 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04367651 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01666893 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00052980 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96535162 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95647919 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92467038 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87479803 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86125041 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84317417 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83214712 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.82682641 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75394874 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69362040 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67714578 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60293370 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57380133 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49204459 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49108500 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45556033 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32857993 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.26601804 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25560687 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24843209 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.23479624 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23342774 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22232605 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21889182 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18449161 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15399964 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.11710890 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11089323 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02947706 |
| 81 | Pertussis_Homo sapiens_hsa05133 | -0.2594600 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2593753 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2548064 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2346098 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2286438 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2216277 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2085653 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2009820 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1950043 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1940024 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | -0.1899152 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1855837 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1792209 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1786483 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1695298 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1672919 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1665175 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1531946 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1513874 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1403185 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1324592 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0967097 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0926118 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0761770 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0746974 |
| 106 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0696819 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0419762 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | -0.0258958 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | -0.0007417 |

